Skip to main content

Hidradenitis Suppurativa

Hidradenitis Suppurativa

Featured

Derm Q&A
Findings from a recent study showed patients with HS have a similar incidence to other well-studied, at-risk patient groups of opioid use, including those with newly diagnosed musculoskeletal pain. Lead study author Sarah Reddy discusses the implications of these findings and the role dermatologists play in identifying patients at-risk for opioid misuse.
News
Hidradenitis suppurativa (HS) is associated with lower quality of life. Findings from a recent study showed arthralgia can exacerbate this burden in patients.
News
The use of complementary and alternative medicine among patients with HS is very common, according to the findings of a recent survey, which also showed nearly 50% of patients did not find conventiona
News
Findings from a recent study showed about 75% of patients with HS had deranged iron status suggestive of iron deficiency, highlighting a possible need to assess iron levels and the need to investigate
News
A recent study showed patients with severe Hurley stage 1 hidradenitis suppurativa experienced improvements and clinical remission following treatment with a combination antibiotic therapy.
Back to Top